Danaher Corporation (DHR)
NYSE$210.74
Market Cap
$150.62B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
555 of 924
Rank in Industry
29 of 49
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
DHR Insider Trading Activity
DHR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $62,113,059 | 17 | 100 |
Related Transactions
| Couchara Georgeann | SVP, Human Resources | 0 | $0 | 1 | $255,483 | $-255,483 |
| SPOON ALAN G | director | 0 | $0 | 2 | $286,008 | $-286,008 |
| FILLER LINDA | director | 0 | $0 | 1 | $1.1M | $-1.1M |
| Ellis Brian W | Senior Vice President - GC | 0 | $0 | 3 | $4.92M | $-4.92M |
| Weidemanis Joakim | Executive Vice President | 0 | $0 | 1 | $5.62M | $-5.62M |
| Raskas Daniel | SVP - Corporate Development | 0 | $0 | 3 | $12.14M | $-12.14M |
| McGrew Matthew | EVP & Chief Financial Officer | 0 | $0 | 2 | $16.26M | $-16.26M |
| Blair Rainer | President & CEO | 0 | $0 | 4 | $21.53M | $-21.53M |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and …
Insider Activity of Danaher Corporation
Over the last 12 months, insiders at Danaher Corporation have bought $0 and sold $62.11M worth of Danaher Corporation stock.
On average, over the past 5 years, insiders at Danaher Corporation have bought $15.37M and sold $137.81M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100 shares for transaction amount of $24,789 was made by RALES MITCHELL P (Chairman of Exec. Committee) on 2022‑05‑16.
List of Insider Buy and Sell Transactions, Danaher Corporation
| 2025-02-07 | Sale | SPOON ALAN G | director | 550 <0.0001% | $206.46 | $113,553 | -0.29% | |
| 2025-01-30 | Sale | Ellis Brian W | Senior Vice President - GC | 5,700 0.0008% | $224.13 | $1.28M | -7.03% | |
| 2024-11-26 | Sale | Raskas Daniel | SVP - Corporate Development | 26,318 0.0036% | $236.59 | $6.23M | -3.26% | |
| 2024-11-25 | Sale | Raskas Daniel | SVP - Corporate Development | 8,370 0.0012% | $238.00 | $1.99M | -3.58% | |
| 2024-08-26 | Sale | Couchara Georgeann | SVP, Human Resources | 952 0.0001% | $268.37 | $255,483 | -10.62% | |
| 2024-08-01 | Sale | FILLER LINDA | director | 3,928 0.0005% | $279.50 | $1.1M | -13.63% | |
| 2024-08-01 | Sale | McGrew Matthew | EVP & Chief Financial Officer | 16,172 0.0022% | $279.84 | $4.53M | -13.63% | |
| 2024-07-31 | Sale | Blair Rainer | President & CEO | 9,007 0.0013% | $280.00 | $2.52M | -12.46% | |
| 2024-07-25 | Sale | Raskas Daniel | SVP - Corporate Development | 14,507 0.002% | $270.51 | $3.92M | -9.85% | |
| 2024-07-25 | Sale | Ellis Brian W | Senior Vice President - GC | 9,600 0.0014% | $275.16 | $2.64M | -9.85% | |
| 2024-05-16 | Sale | Blair Rainer | President & CEO | 9,005 0.0012% | $265.00 | $2.39M | -6.26% | |
| 2024-05-14 | Sale | Blair Rainer | President & CEO | 19,085 0.0025% | $255.00 | $4.87M | -4.19% | |
| 2024-05-10 | Sale | McGrew Matthew | EVP & Chief Financial Officer | 46,377 0.0063% | $253.05 | $11.74M | -1.91% | |
| 2024-05-02 | Sale | SPOON ALAN G | director | 708 <0.0001% | $243.58 | $172,455 | +0.71% | |
| 2024-04-25 | Sale | Weidemanis Joakim | Executive Vice President | 22,433 0.003% | $250.46 | $5.62M | +1.05% | |
| 2024-04-24 | Sale | Blair Rainer | President & CEO | 47,175 0.0063% | $249.22 | $11.76M | -0.84% | |
| 2024-04-24 | Sale | Ellis Brian W | Senior Vice President - GC | 4,000 0.0005% | $250.01 | $1M | -0.84% | |
| 2024-02-26 | Sale | Raskas Daniel | SVP - Corporate Development | 23,757 0.0032% | $252.00 | $5.99M | -0.63% | |
| 2024-02-15 | Sale | LOHR WALTER G | director | 3,289 0.0005% | $251.15 | $826,032 | +0.88% | |
| 2024-02-13 | Sale | Couchara Georgeann | SVP, Human Resources | 2,622 0.0003% | $242.67 | $636,290 | +3.98% |
Total: 449
*Gray background shows transactions not older than one year
Insider Historical Profitability
12.19%
| FILLER LINDA | director | 41149 0.0058% | $8.67M | 4 | 9 | +2.2% |
| EHRLICH DONALD J | director | 123203 0.0172% | $25.96M | 1 | 15 | +10.65% |
| Zerhouni Elias A. | director | 25139 0.0035% | $5.3M | 1 | 2 | +18.68% |
| SCHWIETERS JOHN T | director | 19380 0.0027% | $4.08M | 3 | 6 | +9.73% |
| RALES MITCHELL P | Chairman of Exec. Committee | 3256 0.0005% | $686,169.44 | 9 | 5 | +16.9% |
*Gray background shows insiders who have made transactions during last year
DHR Institutional Investors: Active Positions
| Increased Positions | 1,017 | +38.38% | 34M | +6% |
| Decreased Positions | 1,162 | -43.85% | 32M | -5.57% |
| New Positions | 240 | New | 8M | New |
| Sold Out Positions | 212 | Sold Out | 2M | Sold Out |
| Total Postitions | 2,505 | -5.47% | 574M | +0.44% |
DHR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $12.41M | 8.36% | 59.75M | +315,912 | +0.53% | 2024-12-31 |
| Blackrock, Inc. | $10.43M | 7.02% | 50.21M | +474,765 | +0.95% | 2024-12-31 |
| State Street Corp | $5.69M | 3.83% | 27.38M | -95,413 | -0.35% | 2024-12-31 |
| Wellington Management Group Llp | $4.43M | 2.98% | 21.32M | -2M | -8.53% | 2024-12-31 |
| Fmr Llc | $4.26M | 2.87% | 20.52M | -3M | -13.12% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $3.94M | 2.66% | 18.98M | -1M | -7.28% | 2024-12-31 |
| Capital International Investors | $3.67M | 2.47% | 17.66M | -169,498 | -0.95% | 2024-12-31 |
| Geode Capital Management, Llc | $2.78M | 1.87% | 13.36M | +315,446 | +2.42% | 2024-12-31 |
| Morgan Stanley | $2.43M | 1.63% | 11.68M | +16,363 | +0.14% | 2024-12-31 |
| Norges Bank | $1.93M | 1.3% | 9.28M | +110,156 | +1.2% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.